About
In this episode of Don’t Miss a Beat, Javed Butler, MD, joins hosts Muthiah Vaduganthan, MD, MPH, and Steve Greene, MD, for a breakdown of the EMPACT-MI trial, including primary results, secondary findings, how data from DAPA-MI and EMPACT-MI complement each other, and what is next for the SGLT2 inhibitor class.
Key Highlights:
00:00 - Intro
01:57 - Trial Design and Results
07:00 - Inclusion Criteria and Patient Characteristics
10:53 - Primary Results of EMPACT-MI
14:34 - Subgroup Analyses
15:27 - Implications for Post-MI Patient Population
19:53 - Takehome Messages for Care
23:39 - Kidney Outcomes in Post-MI Patient Population
Key Highlights:
00:00 - Intro
01:57 - Trial Design and Results
07:00 - Inclusion Criteria and Patient Characteristics
10:53 - Primary Results of EMPACT-MI
14:34 - Subgroup Analyses
15:27 - Implications for Post-MI Patient Population
19:53 - Takehome Messages for Care
23:39 - Kidney Outcomes in Post-MI Patient Population